{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "19",
                "@timestamp": "2023-08-19T16:08:33.000033-04:00",
                "@year": "2023",
                "@month": "08"
            },
            "ait:date-sort": {
                "@day": "06",
                "@year": "2023",
                "@month": "06"
            }
        },
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60002620",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Division of Toxicology"},
                                {"$": "Department of Medicine"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"},
                                {"$": "King Chulalongkorn Memorial Hospital"},
                                {"$": "The Thai Red Cross Society"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60002620",
                                    "@dptid": "103183427"
                                },
                                {"@afid": "60031780"},
                                {"@afid": "60022183"},
                                {"@afid": "60028190"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-949091932-041288d3233f80a253b3ab53ba217c53-1",
                            "ce:source-text": "Division of Toxicology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, the Thai Red Cross Society, Bangkok, Thailand",
                            "@dptid": "103183427"
                        },
                        "author": [{
                            "ce:given-name": "Suthimon",
                            "preferred-name": {
                                "ce:given-name": "Suthimon",
                                "ce:initials": "S.",
                                "ce:surname": "Thumtecho",
                                "ce:indexed-name": "Thumtecho S."
                            },
                            "@author-instance-id": "OB2BibRecID-949091932-0cf910db6c52ac70578cb357d7f92606-1",
                            "@seq": "1",
                            "ce:initials": "S.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Thumtecho",
                            "@auid": "57195619939",
                            "@orcid": "0000-0002-8853-6568",
                            "ce:indexed-name": "Thumtecho S."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60002620",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Department of Psychiatry"},
                                {"$": "Center of Excellence in Transgender Health"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"},
                                {"$": "King Chulalongkorn Memorial Hospital"},
                                {"$": "The Thai Red Cross Society"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60002620",
                                    "@dptid": "124049210"
                                },
                                {"@afid": "60031780"},
                                {"@afid": "60022183"},
                                {"@afid": "60028190"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-949091932-25be6bb077f6925c686e9df95a1100bc-1",
                            "ce:source-text": "Department of Psychiatry and Center of Excellence in Transgender Health, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, the Thai Red Cross Society, Bangkok, Thailand",
                            "@dptid": "124049210"
                        },
                        "author": [{
                            "ce:given-name": "Sorawit",
                            "preferred-name": {
                                "ce:given-name": "Sorawit",
                                "ce:initials": "S.",
                                "ce:surname": "Wainipitapong",
                                "ce:indexed-name": "Wainipitapong S."
                            },
                            "@author-instance-id": "OB2BibRecID-949091932-8a2418082100359981f10edd95b6eb4d-1",
                            "@seq": "2",
                            "ce:initials": "S.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Wainipitapong",
                            "@auid": "57219870329",
                            "ce:indexed-name": "Wainipitapong S."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60002620",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60002620"},
                                {"@afid": "60028190"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-949091932-f3248f0ba41b12eaa753200d3abb806e-1",
                            "ce:source-text": "Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand"
                        },
                        "author": [{
                            "ce:given-name": "Polpat",
                            "preferred-name": {
                                "ce:given-name": "Polpat",
                                "ce:initials": "P.",
                                "ce:surname": "Tantakitti",
                                "ce:indexed-name": "Tantakitti P."
                            },
                            "@author-instance-id": "OB2BibRecID-949091932-fdcd03e4a578e7d55776d63db87ead2f-1",
                            "@seq": "3",
                            "ce:initials": "P.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Tantakitti",
                            "@auid": "58304870500",
                            "ce:indexed-name": "Tantakitti P."
                        }]
                    }
                ],
                "citation-title": "Transient depersonalisation/derealisation syndrome from tramadol",
                "abstracts": "© 2023 BMJ Publishing Group. All rights reserved.Depersonalisation/derealisation (DD) syndrome is often associated with severe traumatic experiences and the use of certain medications. Our patient reported experiencing a transient DD phenomenon a few hours after taking 37.5 mg of tramadol, together with etoricoxib, acetaminophen and eperisone. His symptoms subsided upon tramadol discontinuation, suggesting the possibility of tramadol-induced DD. A study of the patient's cytochrome P450 (CYP) 2D6 polymorphism, which mainly metabolises tramadol, indicated normal metaboliser status with reduced function. The concomitant administration of the CYP2D6 inhibitor, etoricoxib, would have led to higher concentrations of the serotonergic parent tramadol, providing an explanation for the patient's symptoms.",
                "correspondence": {
                    "affiliation": {
                        "country": "Thailand",
                        "@country": "tha",
                        "city": "Bangkok",
                        "organization": [
                            {"$": "Division of Toxicology"},
                            {"$": "Department of Medicine"},
                            {"$": "Faculty of Medicine"},
                            {"$": "Chulalongkorn University"},
                            {"$": "King Chulalongkorn Memorial Hospital"},
                            {"$": "The Thai Red Cross Society"}
                        ],
                        "@affiliation-instance-id": "OB2BibRecID-949091932-041288d3233f80a253b3ab53ba217c53-1",
                        "ce:source-text": "Division of Toxicology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, the Thai Red Cross Society, Bangkok, Thailand"
                    },
                    "person": {
                        "ce:given-name": "Suthimon",
                        "@author-instance-id": "OB2BibRecID-949091932-3ef505a851d8fb9978eb1f5e83b11c22-1",
                        "ce:initials": "S.",
                        "ce:surname": "Thumtecho",
                        "ce:indexed-name": "Thumtecho S."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "Drug interactions",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Psychiatry",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Toxicology",
                            "@xml:lang": "eng",
                            "@original": "y"
                        }
                    ]},
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "website": {"ce:e-address": {
                        "$": "http://casereports.bmj.com/",
                        "@type": "email"
                    }},
                    "translated-sourcetitle": {
                        "$": "BMJ Case Reports",
                        "@xml:lang": "eng"
                    },
                    "volisspag": {"voliss": {
                        "@volume": "16",
                        "@issue": "6"
                    }},
                    "@type": "j",
                    "sourcetitle": "BMJ Case Reports",
                    "publicationdate": {
                        "month": "06",
                        "year": "2023",
                        "date-text": {
                            "@xfab-added": "true",
                            "$": "6 June 2023"
                        },
                        "day": "06"
                    },
                    "sourcetitle-abbrev": "BMJ Case Rep.",
                    "@country": "gbr",
                    "issn": {
                        "$": "1757790X",
                        "@type": "electronic"
                    },
                    "publicationyear": {"@first": "2023"},
                    "publisher": {"publishername": "BMJ Publishing Group"},
                    "article-number": "e254909",
                    "@srcid": "19700201654"
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "32",
                                    "classification-description": "Psychiatry"
                                },
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                },
                                {
                                    "classification-code": "38",
                                    "classification-description": "Adverse Reactions Titles"
                                }
                            ]
                        },
                        {
                            "@type": "ASJC",
                            "classification": "2700"
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": "MEDI"
                        }
                    ]},
                    "chemicalgroup": {"chemicals": [
                        {
                            "@source": "esbd",
                            "chemical": [
                                {
                                    "cas-registry-number": [
                                        {"$": "56839-43-1"},
                                        {"$": "64840-90-0"}
                                    ],
                                    "chemical-name": "eperisone"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "202409-33-4"},
                                        {"$": "202409-40-3"}
                                    ],
                                    "chemical-name": "etoricoxib"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "846-49-1"},
                                        {"$": "110032-65-0"},
                                        {"$": "91402-80-1"}
                                    ],
                                    "chemical-name": "lorazepam"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "113-45-1"},
                                        {"$": "298-59-9"}
                                    ],
                                    "chemical-name": "methylphenidate"
                                },
                                {
                                    "cas-registry-number": "103-90-2",
                                    "chemical-name": "paracetamol"
                                },
                                {
                                    "cas-registry-number": "147630-09-9",
                                    "chemical-name": "paracetamol plus tramadol"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "27203-92-5"},
                                        {"$": "36282-47-0"}
                                    ],
                                    "chemical-name": "tramadol"
                                }
                            ]
                        },
                        {
                            "@source": "nlm",
                            "chemical": [
                                {"chemical-name": "Analgesics, Opioid"},
                                {"chemical-name": "Cytochrome P-450 CYP2D6"},
                                {"chemical-name": "Etoricoxib"},
                                {"chemical-name": "Tramadol"}
                            ]
                        }
                    ]}
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2023 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "external-source": "MEDLINE",
                "dbcollection": [
                    {"$": "EMBASE"},
                    {"$": "MEDL"},
                    {"$": "NURSNG"},
                    {"$": "REAXYSCAR"},
                    {"$": "RMC"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "18",
                    "@timestamp": "BST 08:25:22",
                    "@year": "2023",
                    "@month": "08"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2025332934",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "641513715",
                            "@idtype": "associatedPUI"
                        },
                        {
                            "$": "949091932",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20230604438",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "37280010",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "2023265856",
                            "@idtype": "NURSNG"
                        },
                        {
                            "$": "20231804807",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "2023255612",
                            "@idtype": "RMC"
                        },
                        {
                            "$": "20232395230",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "20239020702806",
                            "@idtype": "TPA-ID"
                        },
                        {
                            "$": "85161119083",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85161119083",
                            "@idtype": "SGR"
                        },
                        {
                            "$": "641513715",
                            "@idtype": "PUIsecondary"
                        },
                        {
                            "$": "263706099",
                            "@idtype": "OSIN"
                        }
                    ],
                    "ce:doi": "10.1136/bcr-2023-254909"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "19",
                "reference": [
                    {
                        "ref-fulltext": "Spiegel D, Lewis-Fernández R, Lanius R, et al. Dissociative disorders in DSM-5. Annu Rev Clin Psychol 2013; 9: 299-326. doi:10.1146/annurev-clinpsy-050212-185531",
                        "@reference-instance-id": "OB2BibRecID-949091932-81ed164833c743dd2115bdd315eb2454-1",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Dissociative disorders in DSM-5"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1146/annurev-clinpsy-050212-185531",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84875898442",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "9"},
                                "pagerange": {
                                    "@first": "299",
                                    "@last": "326"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Spiegel",
                                        "ce:indexed-name": "Spiegel D."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Lewis-Fernández",
                                        "ce:indexed-name": "Lewis-Fernandez R."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Lanius",
                                        "ce:indexed-name": "Lanius R."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Annu Rev Clin Psychol"
                        },
                        "ce:source-text": "Spiegel D, Lewis-Fernández R, Lanius R, et al. Dissociative disorders in DSM-5. Annu Rev Clin Psychol 2013; 9: 299-326. doi:10.1146/annurev-clinpsy-050212-185531"
                    },
                    {
                        "ref-fulltext": "Dell PF. Depersonalization: A new look at a neglected syndrome, by M. Sierra J Trauma Dissociation 2011; 12: 401-3. doi:10.1080/15299732.2011.573763",
                        "@reference-instance-id": "OB2BibRecID-949091932-1d40116295096dda97b59f8025716805-2",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Depersonalization: A new look at a neglected syndrome, by M"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1080/15299732.2011.573763",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85130848229",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "12"},
                                "pagerange": {
                                    "@first": "401",
                                    "@last": "403"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "P.F.",
                                "@_fa": "true",
                                "ce:surname": "Dell",
                                "ce:indexed-name": "Dell P.F."
                            }]},
                            "ref-sourcetitle": "Sierra J Trauma Dissociation"
                        },
                        "ce:source-text": "Dell PF. Depersonalization: A new look at a neglected syndrome, by M. Sierra J Trauma Dissociation 2011; 12: 401-3. doi:10.1080/15299732.2011.573763"
                    },
                    {
                        "ref-fulltext": "Chamnanphon M, Wainipitapong S, Wiwattarangkul T, et al. CYP2D6 predicts plasma Donepezil concentrations in a cohort of Thai patients with mild to moderate dementia. Pharmgenomics Pers Med 2020; 13: 543-51. doi:10.2147/PGPM.S276230",
                        "@reference-instance-id": "OB2BibRecID-949091932-82f9344fc82c598a38fb7b2fbb639792-3",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "CYP2D6 predicts plasma Donepezil concentrations in a cohort of Thai patients with mild to moderate dementia"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.2147/PGPM.S276230",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85095813329",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "13"},
                                "pagerange": {
                                    "@first": "543",
                                    "@last": "551"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Chamnanphon",
                                        "ce:indexed-name": "Chamnanphon M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Wainipitapong",
                                        "ce:indexed-name": "Wainipitapong S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Wiwattarangkul",
                                        "ce:indexed-name": "Wiwattarangkul T."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Pharmgenomics Pers Med"
                        },
                        "ce:source-text": "Chamnanphon M, Wainipitapong S, Wiwattarangkul T, et al. CYP2D6 predicts plasma Donepezil concentrations in a cohort of Thai patients with mild to moderate dementia. Pharmgenomics Pers Med 2020; 13: 543-51. doi:10.2147/PGPM.S276230"
                    },
                    {
                        "ref-fulltext": "Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-45. doi:10.1038/clpt.1981.154",
                        "@reference-instance-id": "OB2BibRecID-949091932-0a25af2c27e84c70d2ee92f2b728a3a2-4",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1981"},
                            "ref-title": {"ref-titletext": "A method for estimating the probability of adverse drug reactions"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1038/clpt.1981.154",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "0019799332",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "30"},
                                "pagerange": {
                                    "@first": "239",
                                    "@last": "245"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Naranjo",
                                        "ce:indexed-name": "Naranjo C.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "U.",
                                        "@_fa": "true",
                                        "ce:surname": "Busto",
                                        "ce:indexed-name": "Busto U."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Sellers",
                                        "ce:indexed-name": "Sellers E.M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Pharmacol Ther"
                        },
                        "ce:source-text": "Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-45. doi:10.1038/clpt.1981.154"
                    },
                    {
                        "ref-fulltext": "Cohen PR. Medication-associated depersonalization symptoms: report of transient depersonalization symptoms induced by Minocycline. Southern Medical Journal 2004; 97: 70-3. doi:10.1097/01.SMJ.0000083857.98870.98",
                        "@reference-instance-id": "OB2BibRecID-949091932-b8c87775362989c1c061acb11749934b-5",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2004"},
                            "ref-title": {"ref-titletext": "Medication-associated depersonalization symptoms: Report of transient depersonalization symptoms induced by Minocycline"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1097/01.SMJ.0000083857.98870.98",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "1642539959",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "97"},
                                "pagerange": {
                                    "@first": "70",
                                    "@last": "73"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "P.R.",
                                "@_fa": "true",
                                "ce:surname": "Cohen",
                                "ce:indexed-name": "Cohen P.R."
                            }]},
                            "ref-sourcetitle": "Southern Medical Journal"
                        },
                        "ce:source-text": "Cohen PR. Medication-associated depersonalization symptoms: report of transient depersonalization symptoms induced by Minocycline. Southern Medical Journal 2004; 97: 70-3. doi:10.1097/01.SMJ.0000083857.98870.98"
                    },
                    {
                        "ref-fulltext": "Murphy DL, Mueller EA, Hill JL, et al. Comparative anxiogenic, Neuroendocrine, and other physiologic effects of M-chlorophenylpiperazine given intravenously or orally to healthy volunteers. Psychopharmacology 1989; 98: 275-82. doi:10.1007/BF00444705",
                        "@reference-instance-id": "OB2BibRecID-949091932-3524f966c5a89d59513fefe0475bbdcc-6",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1989"},
                            "ref-title": {"ref-titletext": "Comparative anxiogenic, Neuroendocrine, and other physiologic effects of M-chlorophenylpiperazine given intravenously or orally to healthy volunteers"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1007/BF00444705",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "0024313157",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "98"},
                                "pagerange": {
                                    "@first": "275",
                                    "@last": "282"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Murphy",
                                        "ce:indexed-name": "Murphy D.L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Mueller",
                                        "ce:indexed-name": "Mueller E.A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Hill",
                                        "ce:indexed-name": "Hill J.L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Psychopharmacology"
                        },
                        "ce:source-text": "Murphy DL, Mueller EA, Hill JL, et al. Comparative anxiogenic, Neuroendocrine, and other physiologic effects of M-chlorophenylpiperazine given intravenously or orally to healthy volunteers. Psychopharmacology 1989; 98: 275-82. doi:10.1007/BF00444705"
                    },
                    {
                        "ref-fulltext": "Simeon D, Hollander E, Stein DJ, et al. Induction of depersonalization by the serotonin agonist meta-chlorophenylpiperazine. Psychiatry Res 1995; 58: 161-4. doi:10.1016/0165-1781(95)02538-8",
                        "@reference-instance-id": "OB2BibRecID-949091932-53670d39bf6d06a9af39f4e85e73628e-7",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1995"},
                            "ref-title": {"ref-titletext": "Induction of depersonalization by the serotonin agonist meta-chlorophenylpiperazine"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/0165-1781(95)02538-8",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "0028791636",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "58"},
                                "pagerange": {
                                    "@first": "161",
                                    "@last": "164"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Simeon",
                                        "ce:indexed-name": "Simeon D."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Hollander",
                                        "ce:indexed-name": "Hollander E."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Stein",
                                        "ce:indexed-name": "Stein D.J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Psychiatry Res"
                        },
                        "ce:source-text": "Simeon D, Hollander E, Stein DJ, et al. Induction of depersonalization by the serotonin agonist meta-chlorophenylpiperazine. Psychiatry Res 1995; 58: 161-4. doi:10.1016/0165-1781(95)02538-8"
                    },
                    {
                        "ref-fulltext": "Somer E, Amos-Williams T, Stein DJ. Evidence-based treatment for Depersonalisation-Derealisation disorder (DPRD). BMC Psychol 2013; 1: 20. doi:10.1186/2050-7283-1-20",
                        "@reference-instance-id": "OB2BibRecID-949091932-5b78a8a2e3582c3d99963b934af5ebbe-8",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Evidence-based treatment for Depersonalisation-Derealisation disorder (DPRD)"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1186/2050-7283-1-20",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85016139875",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "1"},
                                "pagerange": {"@first": "20"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Somer",
                                    "ce:indexed-name": "Somer E."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Amos-Williams",
                                    "ce:indexed-name": "Amos-Williams T."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "D.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Stein",
                                    "ce:indexed-name": "Stein D.J."
                                }
                            ]},
                            "ref-sourcetitle": "BMC Psychol"
                        },
                        "ce:source-text": "Somer E, Amos-Williams T, Stein DJ. Evidence-based treatment for Depersonalisation-Derealisation disorder (DPRD). BMC Psychol 2013; 1: 20. doi:10.1186/2050-7283-1-20"
                    },
                    {
                        "ref-fulltext": "Simeon D, Stein DJ, Hollander E. Treatment of depersonalization disorder with Clomipramine. Biol Psychiatry 1998; 44: 302-3. doi:10.1016/s0006-3223(98)00023-7",
                        "@reference-instance-id": "OB2BibRecID-949091932-8ad0c6bd57de4a75856db75dd43b7d46-9",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1998"},
                            "ref-title": {"ref-titletext": "Treatment of depersonalization disorder with Clomipramine"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/s0006-3223(98)00023-7",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "17144473930",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "44"},
                                "pagerange": {
                                    "@first": "302",
                                    "@last": "303"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Simeon",
                                    "ce:indexed-name": "Simeon D."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "D.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Stein",
                                    "ce:indexed-name": "Stein D.J."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Hollander",
                                    "ce:indexed-name": "Hollander E."
                                }
                            ]},
                            "ref-sourcetitle": "Biol Psychiatry"
                        },
                        "ce:source-text": "Simeon D, Stein DJ, Hollander E. Treatment of depersonalization disorder with Clomipramine. Biol Psychiatry 1998; 44: 302-3. doi:10.1016/s0006-3223(98)00023-7"
                    },
                    {
                        "ref-fulltext": "Hollander E, Liebowitz MR, DeCaria C, et al. Treatment of depersonalization with serotonin reuptake blockers. J Clin Psychopharmacol 1990; 10: 200-3.",
                        "@reference-instance-id": "OB2BibRecID-949091932-f6f1321f2716051574e3d449a62cd4fd-10",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1990"},
                            "ref-title": {"ref-titletext": "Treatment of depersonalization with serotonin reuptake blockers"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0025293737",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "10"},
                                "pagerange": {
                                    "@first": "200",
                                    "@last": "203"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Hollander",
                                        "ce:indexed-name": "Hollander E."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.R.",
                                        "@_fa": "true",
                                        "ce:surname": "Liebowitz",
                                        "ce:indexed-name": "Liebowitz M.R."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Decaria",
                                        "ce:indexed-name": "Decaria C."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Psychopharmacol"
                        },
                        "ce:source-text": "Hollander E, Liebowitz MR, DeCaria C, et al. Treatment of depersonalization with serotonin reuptake blockers. J Clin Psychopharmacol 1990; 10: 200-3."
                    },
                    {
                        "ref-fulltext": "Foguet Q, Alvárez MJ, Castells E, et al. Methylphenidate in depersonalization disorder: a case report. Actas Esp Psiquiatr 2011; 39: 75-8.",
                        "@reference-instance-id": "OB2BibRecID-949091932-986eb2123168cff26d7e85fde15b7ac5-11",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Methylphenidate in depersonalization disorder: A case report"},
                            "refd-itemidlist": {"itemid": {
                                "$": "79960972118",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "39"},
                                "pagerange": {
                                    "@first": "75",
                                    "@last": "78"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Q.",
                                        "@_fa": "true",
                                        "ce:surname": "Foguet",
                                        "ce:indexed-name": "Foguet Q."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Alvárez",
                                        "ce:indexed-name": "Alvarez M.J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Castells",
                                        "ce:indexed-name": "Castells E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Actas Esp Psiquiatr"
                        },
                        "ce:source-text": "Foguet Q, Alvárez MJ, Castells E, et al. Methylphenidate in depersonalization disorder: a case report. Actas Esp Psiquiatr 2011; 39: 75-8."
                    },
                    {
                        "ref-fulltext": "Nuller YL, Morozova MG, Kushnir ON, et al. Effect of naloxone therapy on depersonalization: a pilot study. J Psychopharmacol 2001; 15: 93-5. doi:10.1177/026988110101500205",
                        "@reference-instance-id": "OB2BibRecID-949091932-8f8f64ba1f90ae8df8c0d1d4a390269a-12",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2001"},
                            "ref-title": {"ref-titletext": "Effect of naloxone therapy on depersonalization: A pilot study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1177/026988110101500205",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "0034935330",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "15"},
                                "pagerange": {
                                    "@first": "93",
                                    "@last": "95"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Y.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Nuller",
                                        "ce:indexed-name": "Nuller Y.L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.G.",
                                        "@_fa": "true",
                                        "ce:surname": "Morozova",
                                        "ce:indexed-name": "Morozova M.G."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "O.N.",
                                        "@_fa": "true",
                                        "ce:surname": "Kushnir",
                                        "ce:indexed-name": "Kushnir O.N."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Psychopharmacol"
                        },
                        "ce:source-text": "Nuller YL, Morozova MG, Kushnir ON, et al. Effect of naloxone therapy on depersonalization: a pilot study. J Psychopharmacol 2001; 15: 93-5. doi:10.1177/026988110101500205"
                    },
                    {
                        "ref-fulltext": "Gong L, Stamer UM, Tzvetkov MV, et al. Pharmgkb summary: Tramadol pathway. Pharmacogenet Genomics 2014; 24: 374-80. doi:10.1097/FPC.0000000000000057",
                        "@reference-instance-id": "OB2BibRecID-949091932-2fff02130137625196ccd12d481bf019-13",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Pharmgkb summary: Tramadol pathway"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1097/FPC.0000000000000057",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84902292452",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "24"},
                                "pagerange": {
                                    "@first": "374",
                                    "@last": "380"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Gong",
                                        "ce:indexed-name": "Gong L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "U.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Stamer",
                                        "ce:indexed-name": "Stamer U.M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.V.",
                                        "@_fa": "true",
                                        "ce:surname": "Tzvetkov",
                                        "ce:indexed-name": "Tzvetkov M.V."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Pharmacogenet Genomics"
                        },
                        "ce:source-text": "Gong L, Stamer UM, Tzvetkov MV, et al. Pharmgkb summary: Tramadol pathway. Pharmacogenet Genomics 2014; 24: 374-80. doi:10.1097/FPC.0000000000000057"
                    },
                    {
                        "ref-fulltext": "Kassahun K, McIntosh IS, Shou M, et al. Role of human liver cytochrome P4503A in the metabolism of etoricoxib, a novel Cyclooxygenase-2 selective inhibitor. Drug Metab Dispos 2001; 29: 813-20.",
                        "@reference-instance-id": "OB2BibRecID-949091932-9aaba9121bbbb8a99aef2cd66744b403-14",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2001"},
                            "ref-title": {"ref-titletext": "Role of human liver cytochrome P4503A in the metabolism of etoricoxib, a novel Cyclooxygenase-2 selective inhibitor"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0035000968",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "29"},
                                "pagerange": {
                                    "@first": "813",
                                    "@last": "820"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Kassahun",
                                        "ce:indexed-name": "Kassahun K."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "I.S.",
                                        "@_fa": "true",
                                        "ce:surname": "McIntosh",
                                        "ce:indexed-name": "McIntosh I.S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Shou",
                                        "ce:indexed-name": "Shou M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Drug Metab Dispos"
                        },
                        "ce:source-text": "Kassahun K, McIntosh IS, Shou M, et al. Role of human liver cytochrome P4503A in the metabolism of etoricoxib, a novel Cyclooxygenase-2 selective inhibitor. Drug Metab Dispos 2001; 29: 813-20."
                    },
                    {
                        "ref-fulltext": "Yamagiwa T, Amino M, Morita S, et al. A case of torsades de pointes induced by severe QT prolongation after an overdose of Eperisone and Triazolam in a patient receiving nifedipine. Clin Toxicol (Phila) 2010; 48: 149-52. doi:10.3109/15563650903524126",
                        "@reference-instance-id": "OB2BibRecID-949091932-47b4b0955f8641b9084e68e14cc3d9be-15",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "A case of torsades de pointes induced by severe QT prolongation after an overdose of Eperisone and Triazolam in a patient receiving nifedipine"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.3109/15563650903524126",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "77749240111",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "48"},
                                "pagerange": {
                                    "@first": "149",
                                    "@last": "152"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Yamagiwa",
                                        "ce:indexed-name": "Yamagiwa T."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Amino",
                                        "ce:indexed-name": "Amino M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Morita",
                                        "ce:indexed-name": "Morita S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Toxicol (Phila)"
                        },
                        "ce:source-text": "Yamagiwa T, Amino M, Morita S, et al. A case of torsades de pointes induced by severe QT prolongation after an overdose of Eperisone and Triazolam in a patient receiving nifedipine. Clin Toxicol (Phila) 2010; 48: 149-52. doi:10.3109/15563650903524126"
                    },
                    {
                        "ref-fulltext": "Ghaffarinejad A, Mehdizadeh Zare Anari A, Pouya F. 2321-Derealization due to Dextroamphetamine: a rare side effect which could cause premature discontinuation of treatment. European Psychiatry 2013; 28: 1. doi:10.1016/S0924-9338(13)77167-0",
                        "@reference-instance-id": "OB2BibRecID-949091932-7a55a6bf3c8e6da27f2f79092661e417-16",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "2321 - Derealization due to Dextroamphetamine: A rare side effect which could cause premature discontinuation of treatment"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/S0924-9338(13)77167-0",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85162989022",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "28"},
                                "pagerange": {"@first": "1"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Ghaffarinejad",
                                    "ce:indexed-name": "Ghaffarinejad A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Mehdizadeh Zare Anari",
                                    "ce:indexed-name": "Mehdizadeh Zare Anari A."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "F.",
                                    "@_fa": "true",
                                    "ce:surname": "Pouya",
                                    "ce:indexed-name": "Pouya F."
                                }
                            ]},
                            "ref-sourcetitle": "European Psychiatry"
                        },
                        "ce:source-text": "Ghaffarinejad A, Mehdizadeh Zare Anari A, Pouya F. 2321-Derealization due to Dextroamphetamine: a rare side effect which could cause premature discontinuation of treatment. European Psychiatry 2013; 28: 1. doi:10.1016/S0924-9338(13)77167-0"
                    },
                    {
                        "ref-fulltext": "Khazaal Y, Zullino DF. Depersonalization-derealization syndrome induced by Reboxetine. Swiss Med Wkly 2003; 133: 398-9. doi:10.4414/smw.2003.10195",
                        "@reference-instance-id": "OB2BibRecID-949091932-16da78bf6ecb4b9f6157175c6e667a38-17",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "ref-title": {"ref-titletext": "Depersonalization-derealization syndrome induced by Reboxetine"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.4414/smw.2003.10195",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "0041689682",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "133"},
                                "pagerange": {
                                    "@first": "398",
                                    "@last": "399"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Khazaal",
                                    "ce:indexed-name": "Khazaal Y."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "D.F.",
                                    "@_fa": "true",
                                    "ce:surname": "Zullino",
                                    "ce:indexed-name": "Zullino D.F."
                                }
                            ]},
                            "ref-sourcetitle": "Swiss Med Wkly"
                        },
                        "ce:source-text": "Khazaal Y, Zullino DF. Depersonalization-derealization syndrome induced by Reboxetine. Swiss Med Wkly 2003; 133: 398-9. doi:10.4414/smw.2003.10195"
                    },
                    {
                        "ref-fulltext": "Riley TB, Overton PG. Enhancing the efficacy of 5-HT uptake inhibitors in the treatment of attention deficit hyperactivity disorder. Med Hypotheses 2019; 133: 109407. doi:10.1016/j.mehy.2019.109407",
                        "@reference-instance-id": "OB2BibRecID-949091932-3a9bcb2d1fed58235b6fc2aefdb6bb2f-18",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Enhancing the efficacy of 5-HT uptake inhibitors in the treatment of attention deficit hyperactivity disorder"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.mehy.2019.109407",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85072766785",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "133"},
                                "pagerange": {"@first": "109407"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "T.B.",
                                    "@_fa": "true",
                                    "ce:surname": "Riley",
                                    "ce:indexed-name": "Riley T.B."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "P.G.",
                                    "@_fa": "true",
                                    "ce:surname": "Overton",
                                    "ce:indexed-name": "Overton P.G."
                                }
                            ]},
                            "ref-sourcetitle": "Med Hypotheses"
                        },
                        "ce:source-text": "Riley TB, Overton PG. Enhancing the efficacy of 5-HT uptake inhibitors in the treatment of attention deficit hyperactivity disorder. Med Hypotheses 2019; 133: 109407. doi:10.1016/j.mehy.2019.109407"
                    },
                    {
                        "ref-fulltext": "Madden SP, Einhorn PM. Cannabis-induced depersonalization-derealization disorder. Am J Psychiatry Resid J 2018; 13: 3-6. doi:10.1176/appi.ajp-rj.2018.130202",
                        "@reference-instance-id": "OB2BibRecID-949091932-9f9f5f44fe22233699509ff9bcacddf2-19",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Cannabis-induced depersonalization-derealization disorder"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1176/appi.ajp-rj.2018.130202",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85108598078",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "13"},
                                "pagerange": {
                                    "@first": "3",
                                    "@last": "6"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S.P.",
                                    "@_fa": "true",
                                    "ce:surname": "Madden",
                                    "ce:indexed-name": "Madden S.P."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "P.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Einhorn",
                                    "ce:indexed-name": "Einhorn P.M."
                                }
                            ]},
                            "ref-sourcetitle": "Am J Psychiatry Resid J"
                        },
                        "ce:source-text": "Madden SP, Einhorn PM. Cannabis-induced depersonalization-derealization disorder. Am J Psychiatry Resid J 2018; 13: 3-6. doi:10.1176/appi.ajp-rj.2018.130202"
                    }
                ]
            }}
        }
    },
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60002620",
        "affilname": "Faculty of Medicine, Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
        "affiliation-country": "Thailand"
    },
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85161119083",
        "dc:description": "Depersonalisation/derealisation (DD) syndrome is often associated with severe traumatic experiences and the use of certain medications. Our patient reported experiencing a transient DD phenomenon a few hours after taking 37.5 mg of tramadol, together with etoricoxib, acetaminophen and eperisone. His symptoms subsided upon tramadol discontinuation, suggesting the possibility of tramadol-induced DD. A study of the patient's cytochrome P450 (CYP) 2D6 polymorphism, which mainly metabolises tramadol, indicated normal metaboliser status with reduced function. The concomitant administration of the CYP2D6 inhibitor, etoricoxib, would have led to higher concentrations of the serotonergic parent tramadol, providing an explanation for the patient's symptoms.",
        "pubmed-id": "37280010",
        "prism:coverDate": "2023-06-06",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85161119083",
        "dc:creator": {"author": [{
            "ce:given-name": "Suthimon",
            "preferred-name": {
                "ce:given-name": "Suthimon",
                "ce:initials": "S.",
                "ce:surname": "Thumtecho",
                "ce:indexed-name": "Thumtecho S."
            },
            "@seq": "1",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60002620",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
            },
            "ce:surname": "Thumtecho",
            "@auid": "57195619939",
            "author-url": "https://api.elsevier.com/content/author/author_id/57195619939",
            "ce:indexed-name": "Thumtecho S."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85161119083"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85161119083&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85161119083&origin=inward"
            }
        ],
        "source-id": "19700201654",
        "citedby-count": "0",
        "prism:volume": "16",
        "subtype": "ar",
        "dc:title": "Transient depersonalisation/derealisation syndrome from tramadol",
        "openaccess": "0",
        "prism:issn": "1757790X",
        "publishercopyright": "© 2023 BMJ Publishing Group. All rights reserved.",
        "article-number": "e254909",
        "prism:issueIdentifier": "6",
        "subtypeDescription": "Article",
        "prism:publicationName": "BMJ Case Reports",
        "openaccessFlag": "false",
        "prism:doi": "10.1136/bcr-2023-254909",
        "dc:identifier": "SCOPUS_ID:85161119083",
        "dc:publisher": "BMJ Publishing Group"
    },
    "idxterms": {"mainterm": [
        {
            "$": "Analgesics, Opioid",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Cytochrome P-450 CYP2D6",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Depersonalization",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Etoricoxib",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Humans",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Tramadol",
            "@weight": "a",
            "@candidate": "n"
        }
    ]},
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "Drug interactions"
        },
        {
            "@_fa": "true",
            "$": "Psychiatry"
        },
        {
            "@_fa": "true",
            "$": "Toxicology"
        }
    ]},
    "subject-areas": {"subject-area": [{
        "@_fa": "true",
        "$": "Medicine (all)",
        "@code": "2700",
        "@abbrev": "MEDI"
    }]},
    "authors": {"author": [
        {
            "ce:given-name": "Suthimon",
            "preferred-name": {
                "ce:given-name": "Suthimon",
                "ce:initials": "S.",
                "ce:surname": "Thumtecho",
                "ce:indexed-name": "Thumtecho S."
            },
            "@seq": "1",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60002620",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
            },
            "ce:surname": "Thumtecho",
            "@auid": "57195619939",
            "author-url": "https://api.elsevier.com/content/author/author_id/57195619939",
            "ce:indexed-name": "Thumtecho S."
        },
        {
            "ce:given-name": "Sorawit",
            "preferred-name": {
                "ce:given-name": "Sorawit",
                "ce:initials": "S.",
                "ce:surname": "Wainipitapong",
                "ce:indexed-name": "Wainipitapong S."
            },
            "@seq": "2",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60002620",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
            },
            "ce:surname": "Wainipitapong",
            "@auid": "57219870329",
            "author-url": "https://api.elsevier.com/content/author/author_id/57219870329",
            "ce:indexed-name": "Wainipitapong S."
        },
        {
            "ce:given-name": "Polpat",
            "preferred-name": {
                "ce:given-name": "Polpat",
                "ce:initials": "P.",
                "ce:surname": "Tantakitti",
                "ce:indexed-name": "Tantakitti P."
            },
            "@seq": "3",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60002620",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
            },
            "ce:surname": "Tantakitti",
            "@auid": "58304870500",
            "author-url": "https://api.elsevier.com/content/author/author_id/58304870500",
            "ce:indexed-name": "Tantakitti P."
        }
    ]}
}}